Linked Life Data

19058664

Source:http://linkedlifedata.com/resource/pubmed/id/19058664

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-12-8
pubmed:abstractText
Little evidence exists about the risk of venous thromboembolism after coronary artery bypass graft (CABG) surgery. According to available studies, about one fifth of CABG patients develop symptomatic or asymptomatic deep vein thrombosis, whereas less than 1% of patients suffer from clinically evident pulmonary embolism. Deep vein thrombosis and pulmonary embolism may influence the outcome of coronary revascularization in terms of morbidity and mortality in the short and medium-term, but unfortunately no clear consensus still exists regarding proper thromboprophylaxis measures. As the incidence of deep vein thrombosis and pulmonary embolism after CABG is similar to the incidence in patients undergoing general surgery, heparin prophylaxis could be considered targeted on patients' individual prothrombotic risk.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1827-6806
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
740-4
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Thromboprophylaxis against venous thromboembolism after coronary surgery: underevaluated, underused, or both?].
pubmed:affiliation
U.O. di Cardiologia eAngiologia Riabilitativa, Clinica "Le Terrazze", Cunardo (VA). m.ambrosetti@clinicaleterrazze.com
pubmed:publicationType
Journal Article, English Abstract, Review